Working with its clients to ensure a successful outcome in terms of market access, Grove consultants based in Bulgaria provide expert advice in three key areas:
The reimbursement system in Bulgaria is lengthy and complex. While changes to both pricing and reimbursement are likely it will take time to develop a proposal that is workable within the Bulgarian regulatory system and in the context of the Bulgarian National Health Insurance Fund (NHIF).
As in other areas, the Bulgarian Drug Agency (BDA) and the Ministry of Health play a key role in the market for medicines, medical devices, food supplements and cosmetics.
The intricacies and dynamics of the Bulgarian regulatory environment serve to underpin the need for new entrants to work with a local partner to better understand pricing and the reimbursement policy in Bulgaria. Only with this can new market entrants hope to get their own price and reimbursement strategies and subsequent reimbursement application right. With experienced local consultants, Grove can assist with: